Molecular basis for impaired muscle differentiation in myotonic dystrophy

Molecular and Cellular Biology

Volumn 21, Issue 20, 2001, Pages 6927-6938

  Timchenko, N A ^a   Iakova, P ^a   Cai, Z J ^a   Smith, J R ^a   Timchenko, L T ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P21; RNA BINDING PROTEIN;

ARTICLE; CELL CYCLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MUSCLE DEVELOPMENT; MYOBLAST; MYOTONIC DYSTROPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PURIFICATION; RNA TRANSLATION; SKELETAL MUSCLE;

BASE SEQUENCE; BLOTTING, WESTERN; CELL CYCLE; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CELL DIVISION; CELL NUCLEUS; CELL-FREE SYSTEM; CELLS, CULTURED; CLONING, MOLECULAR; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASES; CYTOPLASM; DNA-BINDING PROTEINS; E2F TRANSCRIPTION FACTORS; GENE DELETION; HUMANS; MICROSCOPY, FLUORESCENCE; MODELS, GENETIC; MOLECULAR SEQUENCE DATA; MUSCLE, SKELETAL; MYOTONIC DYSTROPHY; PROTEIN BINDING; PROTEIN BIOSYNTHESIS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS P21(RAS); RIBONUCLEASES; RIBONUCLEOPROTEINS; RNA, MESSENGER; RNA-BINDING PROTEINS; TIME FACTORS; TRANSCRIPTION FACTORS; ULTRAVIOLET RAYS; UP-REGULATION;

EID: 0034806973     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.21.20.6927-6938.2001     Document Type: Article

References (42)

1. Cis and trans effects of the myotonic dystrophy (DM) mutation in a cell culture model
2. Embryonic lethal abnormal visual RNA-binding proteins involved in growth, differentiation, and posttranscriptional gene expression
3. ELAV tumor antigen, Hel-N1, increases translation of neurofilament M mRNA and induces formation of neuritis in human teratocarcinoma cells
4. (CTG)n repeats markedly inhibit differentiation of the C2C12 line: Implications for congenital myotonic dystrophy
5. Mutant alleles at the locus elav in Drosophila melanogaster lead to nervous system defects. A developmental-genetic analysis
6. Myotonic dystrophy: Discussion of molecular mechanism
7. Phosphorylation of the retinoblastoma gene product is modulated during cell cycle and cellular differentiation
8. Expansion of a CUG trinucleotide repeat in the 3′ untranslated region of myotonin protein kinase transcripts results in nuclear retention of transcripts
9. The regulation of E2F by Rb family proteins
10. A family of human RNA-binding proteins related to the Drosophila Bruno translational regulator
11. Ectopic expression of Hel-N1, an RNA-binding protein, increases glucose transporter (GLUT1) expression in 3T3-L1 adipocytes
12. Abnormal myotonic dystrophy protein kinase levels produce only mild myopathy in mice
13. p21 (waf1) mRNA contains a conserved elements in its 3′-untranslated region that is bound by the Elav-like mRNA-stabilizing proteins
14. Direct binding of cyclin D to the retinoblastoma gene product (Rb) and Rb phosphorylation by the cyclin D-dependent kinase CDK4
15. "Mitotic drive" of expanded CCTG repeats in myotonic dystrophy type 1 (DM1)
16. Expression and activity of retinoblastoma protein (pRb)-family proteins, p107 and p130, during L6 myoblast differentiation
17. Mice deficient in Six5 develop cataracts: Implications for myotonic dystrophy
18. Hel-N1: An autoimmune RNA-binding protein with specificity for 3′ uridylate-rich untranslated regions of growth factors mRNAs
19. Cardiac elav-type RNA-binding protein (ETR-3) binds to RNA CUG repeats expanded in myotonic dystrophy
20. Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat
21. Recruitment of human muscle-blind proteins to (CUG)n expansions associated with myotonic dystrophy
22. ETR-1, a homologue of a protein linked to myotonic dystrophy, is essential for muscle development in Caenorhabditis elegans
23. The C-terminal region of p21 is involved in proliferating cell nuclear antigen binding but does not appear to be required for growth inhibition
24. Skeletal muscle cells lacking the retinoblastome protein display defects in muscle gene expression and accumulate in S and G2 phases of the cell cycle
25. Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy
26. Regulation of E2F4 mitogenic activity during terminal differentiation by its heterodimerization partners for nuclear translocation
27. Mice lacking the myotonic dystrophy protein kinase develop a late onset progressive myopathy
28. p57 stabilizes the MyoD protein by inhibiting cyclin E-cdk2 kinase activity in growing myoblasts
29. Altered phosphorylation and intracellular distribution of a (CUG)n triplet repeat RNA-binding protein in patients with myotonic dystrophy and in myotonin protein kinase knockout mice
30. Overexpression of 3′-untranslated region of the myotonic dystrophy kinase cDNA inhibits myoblasts differentiation in vitro
31. Heterozygous loss of Six5 in mice is sufficient to cause ocular cataracts
32. Foci of trinucleotide repeat transcripts in nuclei of myotonic dystrophy cells and tissues
33. Myotonic dystrophy: The role of RNA CUG triplet repeats
34. Identification of a (CUG)n triplet repeat RNA-binding protein and its expression in myotonic dystrophy
35. Novel proteins with binding specificity for DNA CTG repeats and RNA CUG repeats: Implications for myotonic dystrophy
36. RNA CUG repeats sequester CUGBP1 and alter protein levels and activity of CUGBP1
37. CUG repeat binding protein (CUGBP1) interacts with the 5′ region of C/EBPβ mRNA and regulates translation of C/EBPβ isoforms
38. CCAAT/Enhancer binding protein α (C/EBPα) inhibits cell proliferation through p21 protein
39. Myotonic dystrophy: Evidence for a possible dominant-negative RNA mutation
40. HuR regulates p21 mRNA stabilization by UV light
41. Translational induction of Liver-enriched transcriptional inhibitory protein during acute phase response leads to repression of CCAAT/enhancer binding protein a mRNA
42. p21 and p57 control muscle differentiation at the myogenin step